Back to Results
First PageMeta Content
Glaucoma / Blindness / Chemistry / Ophthalmology / Ocular hypertension / Bimatoprost / Ethers / Intraocular pressure / Latanoprost / Medicine / Prostaglandins / Health


Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery
Add to Reading List

Open Document

File Size: 503,75 KB

Share Result on Facebook

City

Wenzhou / Taiyuan / Cary / Irvine / Shanghai / Mundorf / Helsinki / Nanjing / Beijing / Shenyang / /

Company

SAS Institute Inc. / Early Manifest Glaucoma Trial Group / Bernstein / Rosner SA / ITT / 12Allergan Information Consulting (Shanghai) Co. Ltd. / hyperemia AE / Faridi and associates / Balaszi AG / Bayer / LG / GE / Google / Overall AE / Konstas AG / Shanghai Careway Consulting Co. Ltd. / Claridge KG / BioMed Central Ltd. / Allergan Information Consulting (Shanghai) Co. Ltd. / Creative Commons / /

Country

Thailand / China / United States / /

/

Facility

ENT Hospital / Beijing Tongren Hospital / Institute of Ophthalmology / Medical College of Zhejiang University / Affiliated Hospital / Xiamen University / Eye Hospital / Shantou University / People’s Hospital of Jiangsu / Shanghai Medical College / Capital University of Medical Science / University Third Hospital / Fourth People’s Hospital of Shenyang / Centre of Tianjin Medical University / Peking University Eye Center / Chinese University of Hong Kong / Fudan University / Wenzhou Medical College / /

IndustryTerm

therapy of glaucoma / glaucoma treatment / therapy for glaucoma / Hypertension Treatment / treatment for glaucoma / study protocol / treatment of glaucoma / online submission / /

MedicalCondition

severe conjunctival hyperemia / open angle glaucoma / severe hyperemia / POAG primary open-angle glaucoma / either glaucoma / obvious ocular diseases / conjunctival hyperemia grade increase / hyperemia grading scale / hyperemia / hyperemia increase / reported hyperemia cases / ocular hypertension / mild hyperemia / Glaucoma / untreated glaucoma / Headache / open-angle and normal tension glaucoma / J Glaucoma / Chinese primary open-angle glaucoma / hyperemia scoring distribution / Conjunctivitis / conjunctival hyperemia grading / Fatigue / hypersensitivity / bulbar hyperemia grading guide / MS / blindness / mild conjunctival hyperemia / collaborative initial glaucoma / primary open-angle glaucoma / hypertension / conjunctival hyperemia / chronic angle-closure glaucoma / ocular pruritus / severe conjunctival hyperemia approached significance / cardiovascular disease / conjunctiva hyperemia / pain / conjunctival hyperemia evaluation / Chinese glaucoma / open-angle glaucoma / uncontrolled systemic disease / cataract / OHT ocular hypertension / early manifest glaucoma / /

MedicalTreatment

surgery / surgical treatment / laser treatment / /

Organization

Wenzhou Medical College / Xiamen University / 2nd Affiliated Hospital / Chinese University of Hong Kong / Beijing Tongren Hospital / 4Eye Center / Eye & ENT Hospital / 11Eye Institute / Shanghai Medical College / Capital University / People’s Hospital of Jiangsu / Fudan University / 10Eye Centre / Shantou University / International Eye Center / Peking University Eye Center / Department of Ophthalmology / Xiamen Eye Center / 7Eye Hospital / 6Beijing Institute of Ophthalmology / 5Shanxi Eye Hospital / Fudan University / Shanghai / Fourth People’s Hospital of Shenyang / Tianjin Medical University / Tianjin / European Glaucoma Society / Zhejiang University / Hangzhou / Ethics Committee / /

Person

Yan Ke Za Zhi / Chin Med / Aiwu Fang / Qing Liu / Liang Xu / Lingling Wu / Shu V / Jian Ji / Jiamin Hou / Xinghuai Sun / Mingzhi Zhang / Arch Ophthalmol / /

Position

Prime Minister / Curran MP / author / masked-evaluator / multicentre study / treating physician / PG/PM / investigator / Trattler WB / /

Product

FS / PG medication / Latanoprost / Lumigan / /

ProvinceOrState

Jiangsu / Xuhui District / California / Zhejiang / North Carolina / /

Region

Southern China / /

Technology

study protocol / laser / /

URL

http /

SocialTag